University of Minnesota, Mayo Clinic form strategic research relationship with Karolinska Institute

January 24, 2016

Regenerative Medicine -- A field that holds promise for regenerating damaged cells within the body and/or creating replacements in the laboratory. It is a revolutionary approach that focuses on curing conditions as opposed to treating them, and encompasses chronic diseases, such as heart disease and cancer, and degenerative diseases of the nervous and musculoskeletal systems. Bio-Omics -- A phrase that includes several of the most promising fields of biomedical research, including genomics, proteomics, and metabolomics, all of which are strengths of the partnering institutions. Immunity -- Relates to development of new or improved vaccines and therapeutic agents active against infectious agents that already devastate or threaten to devastate large numbers of people living in the developing world, such as HIV/AIDS, tuberculosis, and malaria.

The three-way agreement was celebrated during a recent visit to Minnesota by Harriett Wallberg-Henriksson, M.D., Ph.D., president of the Karolinska Institute. She received an honorary degree from the University of Minnesota. The degree was conferred by University Regent Patricia Simmons, M.D., who was assisted by University President Robert Bruininks, Ph.D., and Mayo Clinic president and CEO, John Noseworthy, M.D.

Source: Mayo Clinic